eNos Antibody (S1177)
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS: 4
- PROTOCOLS
- BACKGROUND
Application
| IF, FC, WB, E |
---|---|
Primary Accession | P29474 |
Other Accession | Q62600, Q28969, P70313, P29473, NP_001153582.1, NP_000594.2, NP_001153581.1, P79209 |
Reactivity | Human |
Predicted | Bovine, Mouse, Pig, Rat, Sheep |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 133275 Da |
Antigen Region | 1156-1183 aa |
Gene ID | 4846 |
---|---|
Other Names | Nitric oxide synthase, endothelial, Constitutive NOS, cNOS, EC-NOS, Endothelial NOS, eNOS, NOS type III, NOSIII, NOS3 |
Target/Specificity | This eNos antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1156-1183 amino acids from human eNos. |
Dilution | IF~~1:10~50 WB~~1:1000 FC~~1:10~50 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | eNos Antibody (S1177) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | NOS3 (HGNC:7876) |
---|---|
Function | Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway (PubMed:1378832). NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. |
Cellular Location | Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Note=Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle; which is favored by interaction with NOSIP and results in a reduced enzymatic activity |
Tissue Location | Platelets, placenta, liver and kidney. |
Provided below are standard protocols that you may find useful for product applications.
Background
Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Multiple transcript variants encoding different isoforms have been found for this gene.
References
Yanamandra, K., et al. Ophthalmic Genet. 31(4):173-177(2010)
Bambha, K., et al. Mayo Clin. Proc. 85(9):814-820(2010)
Shin, S.J., et al. Eur. J. Obstet. Gynecol. Reprod. Biol. 152(1):64-67(2010)
Kim, S.M., et al. Kardiol Pol 68(8):920-926(2010)
Dafni, C., et al. BMC Med. Genet. 11, 133 (2010) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.